You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Analysis of Participant Withdrawal in Huntington Disease Clinical Trials

[Journal of Huntingtons Disease 6(2), 2017, 149-156, DOI 10.3233/JHD-170246]

On page 156, the Acknowledgment section is incomplete. The correct Acknowledgment text is:

The authors thank the CARE-HD, DOMINO, and 2CARE trial participants, their family/caregivers, investigators and coordinators. This work was funded by the Huntington Study Group, the Uehara Memorial Foundation, the Toyoaki Foundation, and the National Institute of Neurological Disorders and Stroke (R01 NS052592 – Coenzyme Q10 in Huntington’s Disease and U01 NS052592 – Coenzyme Q10 in Huntingtons Disease; Coenzyme Q10 in Huntington’s Disease).